1-Phenyl-4(1H)-quinazolinones and 2,3-dihydro-1-phenyl-4(1H)-quinazolinones as potential cholecystokinin receptor ligands
- 1 July 1996
- journal article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 33 (4) , 1163-1170
- https://doi.org/10.1002/jhet.5570330427
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A new method for the resolution of amines and its application to 3-amino-1,5-benzodiazepinesTetrahedron: Asymmetry, 1995
- Diphenylpyrazolidinone and benzodiazepine cholecystokinin antagonists: A case of convergent evolution in medicinal chemistryBioorganic & Medicinal Chemistry Letters, 1993
- Quinazolinone cholecystokinin-B receptor ligandsJournal of Medicinal Chemistry, 1991
- Cholecystokinin receptor subtypes and neuromodulationProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1989
- Synthesis of (.+-.)-catharanthine, (+)-anhydrovinblastine, and (-)-anhydrovincovalineJournal of the American Chemical Society, 1987
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.Proceedings of the National Academy of Sciences, 1986
- Role of cholecystokinin and opioid peptides in control of food intakePhysiological Reviews, 1986
- Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligandJournal of Neuroscience, 1984
- Studies on 4(1H)-quinazolinones. III. Some derivatizations of 2-ethoxycarbonylalkyl-1-substituted-4(1H)-quinazolinones.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Distinct cholecystokinin receptors in brain and pancreas.Proceedings of the National Academy of Sciences, 1980